Editas Medicine (EDIT)
(Delayed Data from NSDQ)
$5.50 USD
+0.01 (0.18%)
Updated Apr 22, 2024 11:56 AM ET
After-Market: $5.62 +0.12 (2.18%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Brokerage Reports
0 items in cart
Editas Medicine, Inc. [EDIT]
Reports for Purchase
Showing records 1 - 20 ( 95 total )
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for EDIT 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department